In addition to treating MI, growth factor/IgG complexes or FGF2/Fc-fusion complexes may be well suited to improve tissue survival and function after organ transplantation or to treat other forms of injury such as diabetic neuropathy, peripheral artery disease, chronic ulcer, and stroke. The gene discussed is FGF2; the disease is diabetic neuropathy.